News
CMOPF
69.75
NaN%
--
Weekly Report: what happened at CMOPF last week (1109-1113)?
Weekly Report · 6d ago
Weekly Report: what happened at CMOPF last week (1102-1106)?
Weekly Report · 11/09 10:29
Weekly Report: what happened at CMOPF last week (1026-1030)?
Weekly Report · 11/02 10:29
Weekly Report: what happened at CMOPF last week (1019-1023)?
Weekly Report · 10/26 10:28
Weekly Report: what happened at CMOPF last week (1012-1016)?
Weekly Report · 10/19 10:28
Cosmo’s Rifamycin Gel Hits Key Phase 2 Mark in Distal Ulcerative Colitis
TipRanks · 10/19 05:37
Cosmo Announces Positive Phase 2 Study of Rifamycin 1% Topically Acting Gel, Meeting the Primary Endpoint in Distal Ulcerative Colitis and Ulcerative Proctitis
Newsfile · 10/19 05:09
Weekly Report: what happened at CMOPF last week (1005-1009)?
Weekly Report · 10/12 10:35
Weekly Report: what happened at CMOPF last week (0928-1002)?
Weekly Report · 10/05 10:34
Weekly Report: what happened at CMOPF last week (0921-0925)?
Weekly Report · 09/28 10:28
Weekly Report: what happened at CMOPF last week (0914-0918)?
Weekly Report · 09/21 10:29
Cosmo’s GI Genius AI System Boosts Adenoma Detection in Major VA Study
TipRanks · 09/21 05:32
Largest Real-World Study of the GI Genius(TM) Intelligent Endoscopy System Demonstrates Improved Adenoma Detection in Routine Clinical Practice
Newsfile · 09/21 05:07
Weekly Report: what happened at CMOPF last week (0907-0911)?
Weekly Report · 09/14 10:35
Weekly Report: what happened at CMOPF last week (0831-0904)?
Weekly Report · 09/07 10:27
Weekly Report: what happened at CMOPF last week (0824-0828)?
Weekly Report · 08/31 10:35
Weekly Report: what happened at CMOPF last week (0817-0821)?
Weekly Report · 08/24 10:36
Weekly Report: what happened at CMOPF last week (0810-0814)?
Weekly Report · 08/17 10:37
Cosmo Pharmaceuticals to Change SIX Ticker to CMHC, Aligning Brand With Health-Focused Strategy
TipRanks · 08/14 05:32
Cosmo Announces SIX Ticker Symbol Change to "CMHC"
Newsfile · 08/14 05:22
More
Webull provides a variety of real-time CMOPF stock news. You can receive the latest news about Cosmo Pharmaceuticals Nv through multiple platforms. This information may help you make smarter investment decisions.
About CMOPF
Cosmo N.V. formerly known as COSMO Pharmaceuticals N.V. is an Ireland based pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases, dermatology, and healthtech. Its development pipeline includes Distal Ulcerative Colitis, Bile Acid Diarrhea, Solid Tumors, and AI Augmented Endoscopy. The Company's developed products include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, which is used for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, which is a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo, which is used for the treatment of travelers’ diarrhea (TD); Methylene Blue MMX, which is a diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy, and Winlevi, which is used for the treatment of acne. It also develops medical devices to assist with clinical decision-making.